OBSTRUCTIVE SLEEP APNEA SYNDROME IN CHILDREN WITH TYPE II MUCOPOLYSACCHARIDOSIS (HUNTER SYNDROME)

17 children received cardiorespiratory monitoring in order to evaluate spread and dynamics of changes in the primary obstructive sleep apnea syndrome (OSAS) parameters at type II mucopolysaccharidosis. Mild OSAS [apnea/hypopnea index (AHI) – 1.5-5] was diagnosed in 4 patients (23.5%), moderate OSAS...

Full description

Saved in:
Bibliographic Details
Main Authors: N. D. Vashakmadze, L. S. Namazova-Baranova, A. K. Gevorkyan, V. V. Altunin, L. M. Kuzenkova, E. G. Chernavina, M. A. Babaykina, T. V. Podkletnova, O. V. Kozhevnikova
Format: Article
Language:Russian
Published: Union of pediatricians of Russia 2013-11-01
Series:Педиатрическая фармакология
Subjects:
Online Access:https://www.pedpharma.ru/jour/article/view/161
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850045994671013888
author N. D. Vashakmadze
L. S. Namazova-Baranova
A. K. Gevorkyan
V. V. Altunin
L. M. Kuzenkova
E. G. Chernavina
M. A. Babaykina
T. V. Podkletnova
O. V. Kozhevnikova
author_facet N. D. Vashakmadze
L. S. Namazova-Baranova
A. K. Gevorkyan
V. V. Altunin
L. M. Kuzenkova
E. G. Chernavina
M. A. Babaykina
T. V. Podkletnova
O. V. Kozhevnikova
author_sort N. D. Vashakmadze
collection DOAJ
description 17 children received cardiorespiratory monitoring in order to evaluate spread and dynamics of changes in the primary obstructive sleep apnea syndrome (OSAS) parameters at type II mucopolysaccharidosis. Mild OSAS [apnea/hypopnea index (AHI) – 1.5-5] was diagnosed in 4 patients (23.5%), moderate OSAS (AHI – 5-10) – in 4 patients (23.5%), severe OSAS (AHI>10) – in 2 patients (11.8%). Average AHI at Hunter syndrome was 5.3±6.9/hour. Mild OSAS (AHI – 0.8±0.3/hour) was prevalent in the group of younger children (1-3 years of age); severe OSAS was prevalent in the group of adolescents (AHI – 10.9±9.4/hour); average blood oxygen saturation (SpO2) was 87.5±10.6%, desaturation index – 10.4±13.3/hour. In total, OSAS was observed in 58.8% of children and aggravated in direct proportion to aggravation of the disease course. Thus, cardiorespiratory monitoring is necessary to reveal children with moderate and severe OSAS course with subsequent prevention of life-threatening conditions, which may appear at this syndrome.
format Article
id doaj-art-220644e28d7a4aebb6c909983333d07b
institution DOAJ
issn 1727-5776
2500-3089
language Russian
publishDate 2013-11-01
publisher Union of pediatricians of Russia
record_format Article
series Педиатрическая фармакология
spelling doaj-art-220644e28d7a4aebb6c909983333d07b2025-08-20T02:54:33ZrusUnion of pediatricians of RussiaПедиатрическая фармакология1727-57762500-30892013-11-01106768110.15690/pf.v10i6.900161OBSTRUCTIVE SLEEP APNEA SYNDROME IN CHILDREN WITH TYPE II MUCOPOLYSACCHARIDOSIS (HUNTER SYNDROME)N. D. Vashakmadze0L. S. Namazova-Baranova1A. K. Gevorkyan2V. V. Altunin3L. M. Kuzenkova4E. G. Chernavina5M. A. Babaykina6T. V. Podkletnova7O. V. Kozhevnikova8Scientific Center of Children’s Health, Moscow, Russian FederationScientific Center of Children’s Health, Moscow, Russian Federation First Sechenov Moscow State Medical University of the Ministry of Health of the Russian Federation Pirogov Russian National Medical Research University, MoscowScientific Center of Children’s Health, Moscow, Russian Federation First Sechenov Moscow State Medical University of the Ministry of Health of the Russian FederationScientific Center of Children’s Health, Moscow, Russian FederationScientific Center of Children’s Health, Moscow, Russian Federation First Sechenov Moscow State Medical University of the Ministry of Health of the Russian FederationScientific Center of Children’s Health, Moscow, Russian FederationScientific Center of Children’s Health, Moscow, Russian FederationScientific Center of Children’s Health, Moscow, Russian FederationScientific Center of Children’s Health, Moscow, Russian Federation17 children received cardiorespiratory monitoring in order to evaluate spread and dynamics of changes in the primary obstructive sleep apnea syndrome (OSAS) parameters at type II mucopolysaccharidosis. Mild OSAS [apnea/hypopnea index (AHI) – 1.5-5] was diagnosed in 4 patients (23.5%), moderate OSAS (AHI – 5-10) – in 4 patients (23.5%), severe OSAS (AHI>10) – in 2 patients (11.8%). Average AHI at Hunter syndrome was 5.3±6.9/hour. Mild OSAS (AHI – 0.8±0.3/hour) was prevalent in the group of younger children (1-3 years of age); severe OSAS was prevalent in the group of adolescents (AHI – 10.9±9.4/hour); average blood oxygen saturation (SpO2) was 87.5±10.6%, desaturation index – 10.4±13.3/hour. In total, OSAS was observed in 58.8% of children and aggravated in direct proportion to aggravation of the disease course. Thus, cardiorespiratory monitoring is necessary to reveal children with moderate and severe OSAS course with subsequent prevention of life-threatening conditions, which may appear at this syndrome.https://www.pedpharma.ru/jour/article/view/161obstructive sleep apnea syndromehunter syndromecardiorespiratory monitoringchildren
spellingShingle N. D. Vashakmadze
L. S. Namazova-Baranova
A. K. Gevorkyan
V. V. Altunin
L. M. Kuzenkova
E. G. Chernavina
M. A. Babaykina
T. V. Podkletnova
O. V. Kozhevnikova
OBSTRUCTIVE SLEEP APNEA SYNDROME IN CHILDREN WITH TYPE II MUCOPOLYSACCHARIDOSIS (HUNTER SYNDROME)
Педиатрическая фармакология
obstructive sleep apnea syndrome
hunter syndrome
cardiorespiratory monitoring
children
title OBSTRUCTIVE SLEEP APNEA SYNDROME IN CHILDREN WITH TYPE II MUCOPOLYSACCHARIDOSIS (HUNTER SYNDROME)
title_full OBSTRUCTIVE SLEEP APNEA SYNDROME IN CHILDREN WITH TYPE II MUCOPOLYSACCHARIDOSIS (HUNTER SYNDROME)
title_fullStr OBSTRUCTIVE SLEEP APNEA SYNDROME IN CHILDREN WITH TYPE II MUCOPOLYSACCHARIDOSIS (HUNTER SYNDROME)
title_full_unstemmed OBSTRUCTIVE SLEEP APNEA SYNDROME IN CHILDREN WITH TYPE II MUCOPOLYSACCHARIDOSIS (HUNTER SYNDROME)
title_short OBSTRUCTIVE SLEEP APNEA SYNDROME IN CHILDREN WITH TYPE II MUCOPOLYSACCHARIDOSIS (HUNTER SYNDROME)
title_sort obstructive sleep apnea syndrome in children with type ii mucopolysaccharidosis hunter syndrome
topic obstructive sleep apnea syndrome
hunter syndrome
cardiorespiratory monitoring
children
url https://www.pedpharma.ru/jour/article/view/161
work_keys_str_mv AT ndvashakmadze obstructivesleepapneasyndromeinchildrenwithtypeiimucopolysaccharidosishuntersyndrome
AT lsnamazovabaranova obstructivesleepapneasyndromeinchildrenwithtypeiimucopolysaccharidosishuntersyndrome
AT akgevorkyan obstructivesleepapneasyndromeinchildrenwithtypeiimucopolysaccharidosishuntersyndrome
AT vvaltunin obstructivesleepapneasyndromeinchildrenwithtypeiimucopolysaccharidosishuntersyndrome
AT lmkuzenkova obstructivesleepapneasyndromeinchildrenwithtypeiimucopolysaccharidosishuntersyndrome
AT egchernavina obstructivesleepapneasyndromeinchildrenwithtypeiimucopolysaccharidosishuntersyndrome
AT mababaykina obstructivesleepapneasyndromeinchildrenwithtypeiimucopolysaccharidosishuntersyndrome
AT tvpodkletnova obstructivesleepapneasyndromeinchildrenwithtypeiimucopolysaccharidosishuntersyndrome
AT ovkozhevnikova obstructivesleepapneasyndromeinchildrenwithtypeiimucopolysaccharidosishuntersyndrome